Novartis Reports Positive Results From Phase III ASC4FIRST Trial; Meets Both Primary Endpoints

Novartis AG (NVS) reported Friday positive results from the pivotal Phase III ASC4FIRST trial, which met both primary endpoints with clinically meaningful and statistically significant results. Scemblix (asciminib) demonstrated superior MMR rates at week 48 vs. investigator-selected SoC TKIs (imatinib, nilotinib, dasatinib and bosutinib) (67.7% vs. 49.0%) and imatinib alone Scemblix also demonstrated a favorable...

Read More

UBS Group Closes Takeover Of Credit Suisse

UBS Group AG (UBS) announces Friday that it has completed the merger of UBS AG and Credit Suisse AG. The completion of the merger within the expected timeline was facilitated by the strong support from regulators across the globe. Credit Suisse has been deregistered in the Commercial Register of the Canton of Zurich and has...

Read More

Singapore Bourse May Extend Winning Streak

The Singapore stock market has moved higher in wo straight sessions collecting almost 15 points or 0.5 percent along the way. The Straits Times Index now rests just above the 3,335-point plateau and it may add to its winnings on Monday. The global forecast for the Asian markets is cautiously optimistic on an improved outlook...

Read More

Taiwan Shares Due For Support On Monday

The Taiwan stock market has finished lower in three consecutive sessions, surrendering almost 700 points or 3.4 percent along the way. The Taiwan Stock Exchange now rests just above the 21,170-point plateau although it may stop the bleeding on Monday. The global forecast for the Asian markets is cautiously optimistic on an improved outlook for...

Read More

China Bourse May End Losing Streak On Monday

The China stock market has finished lower in two straight sessions, shedding almost 30 points or 1 percent along the way. The Shanghai Composite Index now sits just above the 3,085-point plateau although it\'s likely to find traction on Monday. The global forecast for the Asian markets is cautiously optimistic on an improved outlook for...

Read More